• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Characterization of Tachykinin Receptors

        互联网

        888
        • Abstract
        • Table of Contents
        • Materials
        • Figures
        • Literature Cited

        Abstract

         

        The mammalian tachykinin peptides are a family of neuropeptides characterized by a common C?terminal amino acid sequence of the form Phe?X?Gly?Leu?Met?NH2 , where X is either Phe or Val. Tachykinin peptides have various biological activities, including excitation of both peripheral and central neurons, stimulation of smooth muscle contraction, stimulation of exocrine and endocrine gland secretion, and involvement in immune and inflammatory responses. This unit presents basic methods for the characterization of tachykinin receptors by radioligand binding assay. The protocols detail methods for three major classes of tachykinin receptors and techniques for the generation of high specific activity iodinated radioligands.

             
         
        GO TO THE FULL PROTOCOL:
        PDF or HTML at Wiley Online Library

        Table of Contents

        • Basic Protocol 1: Competition Binding Assay for NK1 or NK2 Receptor–Bearing Cells and Tissues
        • Alternate Protocol 1: Competition Binding Assay for NK3 Receptor–Bearing Cells and Tissues
        • Basic Protocol 2: Saturation Binding Assay for NK1 or NK2 Receptor–Bearing Cells and Tissues
        • Alternate Protocol 2: Saturation Binding Assay for NK3 Receptor–Bearing Cells and Tissues
        • Support Protocol 1: Radioiodination of the Tachykinin Peptides
        • Support Protocol 2: Preparation of Membrane from Tissue Bearing Tachykinin Receptors
        • Reagents and Solutions
        • Commentary
        • Figures
        • Tables
             
         
        GO TO THE FULL PROTOCOL:
        PDF or HTML at Wiley Online Library

        Materials

        Basic Protocol 1: Competition Binding Assay for NK1 or NK2 Receptor–Bearing Cells and Tissues

          Materials
        • Cells or tissue membrane preparations to be assayed (see protocol 6 )
        • Radioligand peptide: e.g., 2175 Ci/mmol [125 I]Tyr−1 ‐substance P ([125 I]Tyr−1 ‐SP for NK 1 ), [125 I]histidyl–neurokinin A ([125 I]histidyl‐NKA for NK 2 ), or other 125 I‐labeled tachykinin peptide (NEN Life Science, Amersham, or see protocol 5 )
        • Unlabeled Tyr−1 ‐SP, NKA, or other tachykinin peptide (Bachem)
        • Test compound (competitor)
        • 0.2% (v/v) polyethyleneimine (PEI; Sigma)
        • NK 1 /NK 2 cell binding buffer (see recipe ), ice cold
        • Membrane binding buffer (see recipe ), ice cold
        • PBS, ice cold: 50 mM sodium phosphate buffer, pH 7.4 ( appendix 2A ), containing 120 mM NaCl
        • Tris‐buffered saline (TBS)/MnCl 2 , ice cold: 50 mM Tris⋅Cl, pH 7.4 ( appendix 2A ), containing 120 mM NaCl and 3 mM MnCl 2
        • Tissue culture tubes
        • 2.5‐cm no. 32 glass filters (Schleicher & Schuell)
        • 12 × 75–mm plastic and glass tubes
        • Platform shaker at 4°C
        • Vacuum filtration manifold or other type of membrane‐harvesting apparatus
        • γ scintillation counter

        Alternate Protocol 1: Competition Binding Assay for NK3 Receptor–Bearing Cells and Tissues

        • Tris‐buffered saline (TBS), ice cold: 50 mM Tris⋅Cl, pH 7.4 ( appendix 2A ), containing 120 mM NaCl
        • 66 to 69 Ci/mmol [3 H]senktide (NEN Life Science) radioligand solution
        • NK 3 cell binding buffer (see recipe ) or membrane binding buffer (see recipe ), ice cold
        • Unlabeled senktide (Bachem)
        • TBS/BSA/Tween 20: TBS containing 2% (w/v) BSA and 0.1% (w/v) Tween 20 (Sigma)
        • TBS/0.01% (w/v) SDS
        • Liquid scintillation solution (e.g., ScintiSafe 30%; Fisher)
        • 5‐ml liquid scintillation vials
        • Liquid scintillation counter

        Basic Protocol 2: Saturation Binding Assay for NK1 or NK2 Receptor–Bearing Cells and Tissues

          Materials
        • Cells or tissue membrane preparations to be assayed (see protocol 6 )
        • Radioligand peptide: e.g., 2175 Ci/mmol [125 I]Tyr−1 ‐substance P ([125 I]Tyr−1 ‐SP for NK 1 ), [125 I]histidyl–neurokinin A ([125 I]histidyl‐NKA for NK 2 ), or other 125 I‐labeled tachykinin peptide (NEN Life Science, Amersham, or see protocol 5 )
        • Unlabeled Tyr−1 ‐SP, NKA, or other tachykinin peptide (Bachem)
        • 0.2% (v/v) polyethyleneimine (PEI; Sigma)
        • For cells:
        • NK 1 /NK 2 cell binding buffer (see recipe ), ice cold
        • PBS, ice cold: 50 mM phosphate buffer, pH 7.4 ( appendix 2A ), containing 120 mM NaCl
        • For membranes:
        • Membrane binding buffer (see recipe ), ice cold
        • Tris‐buffered saline (TBS)/MnCl 2 , ice cold: 50 mM Tris⋅Cl, pH 7.4 ( appendix 2A ), containing 120 mM NaCl and 3 mM MnCl 2
        • Tissue culture tubes
        • 2.5‐cm no. 32 glass filters (Schleicher & Schuell)
        • 12 × 75–mm plastic and glass tubes
        • Platform shaker at 4°C
        • Vacuum filtration manifold or other type of membrane‐harvesting apparatus
        • γ scintillation counter
        • Computer program for analysis of binding data (e.g., LIGAND)

        Alternate Protocol 2: Saturation Binding Assay for NK3 Receptor–Bearing Cells and Tissues

          Materials
        • Tachykinin peptide (>95% purity by HPLC; Bachem): e.g., Tyr−1 ‐substance P (Tyr−1 ‐SP), neurokinin A (NKA), Tyr−1 ‐NKA, neuropeptide γ (NPγ), or [MePhe7 ]NKB
        • 0.1% (v/v) trifluoroacetic acid (TFA)
        • 80% (v/v) acetonitrile in 0.1% TFA
        • Chloramine‐T (Sigma)
        • Sodium metabisulfite (Sigma)
        • Bovine serum albumin (BSA; Sigma)
        • 0.2 M sodium phosphate buffer, pH 7.4 ( appendix 2A ) and pH 8.5
        • 1 mCi Na125 I, carrier free (NENsure vial; NEN Life Science)
        • HPLC solvent A: 0.1 M phosphoric acid (HPLC grade) containing 0.1 M NaH 2 PO 4 , pH 2.5
        • HPLC solvent B: 100% acetonitrile (HPLC grade)
        • 2‐Mercaptoethanol (2‐ME; Sigma)
        • Sep‐Pak cartridge Classic (Waters Division of Millipore)
        • 10‐ml and 3‐ml disposable syringes with Luer‐lock tip
        • 0.5‐ml and 1.5‐ml plastic, conical microcentrifuge tubes
        • 12 × 75–mm plastic and glass tubes
        • SpeedVac evaporator (Savant)
        • Tabletop 65°C water bath
        • Programmable HPLC system utilizing separate columns (e.g., 15‐cm analytical Vydac C 4 ) and injectors
        • γ scintillation counter

        Support Protocol 1: Radioiodination of the Tachykinin Peptides

          Materials
        • Receptor‐containing tissue
        • Tris‐buffered saline (TBS), ice cold: 50 mM Tris⋅Cl buffer, pH 7.4 , containing 120 mM NaCl
        • 50 mM Tris⋅Cl, pH 7.4 ( appendix 2A ), ice cold
        • 50 mM Tris⋅Cl, pH 7.4 , containing 300 mM KCl and 10 mM EDTA, ice cold
        • TBS containing 3 mM MnCl 2 , ice cold
        • Polytron and Teflon/glass (Dounce) homogenizers
        • Additional reagents and equipment for determining protein concentration ( appendix 3A )
        GO TO THE FULL PROTOCOL:
        PDF or HTML at Wiley Online Library

        Figures

        •   Figure 1.15.1 Results from a representative competition radioligand binding experiment using [125 I]Tyr−1 ‐NKA as the radioligand (220,000 cpm/tube or 0.045 nM) and NKB as the competitor (concentrations are indicated). CHO cells expressing cloned rat NK2 receptor (700,000 receptors/cell) were used as the receptor source. The binding assay was performed as described (see ). (A ) Competition curve. (B ) Hill transformation plot (see step , ). Solving the equation when y = 0 gives x = log[IC50 ] = −7.3495; therefore, the IC50 for NKB = 44.7 nM.
          View Image
        •   Figure 1.15.2 Example of data output from a representative saturation equilibrium radioligand binding experiment using [3 H]senktide (concentrations are indicated). CHO cells expressing cloned human NK3 receptor were used as the receptor source. Nonspecific binding was defined with a 1000‐fold excess of unlabeled senktide. The binding assay was performed as described (see ). The inset is a Scatchard plot of the data. The values presented for K d and B max are the averages from four independent experiments. The values were obtained by a nonlinear least‐squares analysis using the LIGAND program. (Plotted data are from Krause et al., )
          View Image
        •   Figure 1.15.3 Examples of HPLC separation of unlabeled and radioiodinated Tyr−1 ‐SP species by reversed‐phase HPLC. (A ) HPLC separation of the radioiodinated material (see ); (B ) HPLC trace of intact (unlabeled) Tyr−1 ‐SP. In both panels, the HPLC solvent gradient progression is illustrated by the horizontal line rising from left to right. Small black arrows 1 and 2 represent peaks of unlabeled SP species: peak 1 is the reduced peptide (intact form), elution time 35 min; peak 2 is the oxidized peptide (methylsulfoxide form), elution time 27 min. The other peaks represent material originating from ingredients of radioiodination reaction (e.g., BSA, 2‐ME). Small black arrows 3 and 4 represent elution times of [125 I]Tyr−1 ‐SP species: arrow 3 indicates the fraction containing oxidized [125 I]Tyr−1 ‐SP, elution time 33 min, yield 104.3 µCi/ml; arrow 4 indicates the fraction containing reduced [125 I]Tyr−1 ‐SP, elution time 40 min, yield 603.8 µCi/ml or 60% of incorporation from total 1 mCi 125 I used in the reaction. The total amount of iodinated SP = activity collected/specific activity of 125 I (2175 Ci/mmol) = 603.8 µCi/ml = 277.6 pmol/ml = 2.175 µCi/pmol.
          View Image

        Videos

        Literature Cited

        Literature Cited
           Cheng, Y.‐C. and Prusoff, W.H. 1973. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem. Pharm. 22:3099‐3108.
           Hanley, M.R., Sandberg, B.E.B., Lee, C.M., Iversen, L.L., Brundish, D.E., and Wade, R. 1980. Specific binding of 3H‐substance P to rat brain membranes. Nature 286:810‐812.
           Krause, J.E., Blount, P., and Sachais, B.B. 1994. Molecular biology of receptors: Structures, expression and regulatory mechanisms. In The Tachykinin Receptors (S.H. Buck, ed.) pp. 165‐218. Humana Press, Totowa, N.J.
           Krause, J.E., Staveteig, P.T., Nave‐Mentzer, J., Schmidt, S.K., Tucker, J.B., Brodbeck, R.M., Bu, J.‐Y., and Karpitskiy, V.V. 1997. Functional expression of a novel human neurokinin‐3 receptor homologue that binds [3H]senktide and [125I‐MePhe7]‐NKB, and is responsive to tachykinin peptide agonist. Proc. Natl. Acad. Sci. U.S.A. 94:310‐315.
           Lee, C.M., Iversen, L.L., Hanley, M.R., and Sandberg, B.E.B. 1982. The possible existence of multiple receptors for substance P. Naunyn‐Schmiedeberg's Arch. Pharmacol. 318:281‐287.
           Maggi, C.A., Patacchine, R., Rovero, P., and Giachetti, A. 1993. Tachykinin receptors and tachykinin receptor antagonists. J. Autonom. Pharmacol. 13:23‐93.
           Munson, P.J. and Rodbard, D. 1980. LIGAND: A versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107:220‐239.
           Nakanishi, S. 1991. Mammalian tachykinin receptors. Annu. Rev. Neurosci. 14:123‐136.
           Otsuka, M. and Yoshioka, K. 1993. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:229‐308.
        Key References
           Cheng and Prusoff, 1973. See above.
           Describes the appropriate level of substrate to use in competition binding experiments such that IC50 values are equal to Ki values.
           Limbird, L.E. 1986. Cell Surface Receptors: A Short Course of Theory and Methods. Martinus Nij‐hoff Publishing, Zoetermeer, The Netherlands.
           An excellent source of basic information about theoretical and practical aspects of ligand‐receptor interactions.
           Munson and Rodbard, 1980. See above.
           Describes a computerized method to determine Kd and number of binding sites.
           Takeda, Y., Cremins, J.D., Takeda, J., and Krause, J.E. 1991. Analysis of tachykinin peptide family gene expression patterns by combined high‐performance liquid chromatography‐radioimmunoassay. Methods Neurosci. 6:119‐130.
           Describes HPLC procedures and conditions for separating closely related peptides.
        GO TO THE FULL PROTOCOL:
        PDF or HTML at Wiley Online Library
         
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序